Shenzhen International BT Leadership Summit

This article is an orphan, as no other articles link to it. Please introduce links to this page from related articles; try the Find link tool for suggestions. (November 2018)

Shenzhen International BT Leadership Summit (simplified Chinese: 深圳国际BT领袖峰会; traditional Chinese: 深圳國際BT領袖峰會) is a biology-focused business conference. It is held each year in September. It is arranged by the Shenzhen Municipal People's Government. It is held at the Shenzhen Convention and Exhibition Center.

The Shenzhen government development emphasizes biology and the life science industry as an important element of economic guidance and industrial restructuring. The government issued an industrial development plan for biology and life science industry to give strong support for policies, funds, projects and talents.

Structure

The Summit is composed of three parts: speeches, dialogue and a professional forum. Under the aim of “Committed to accelerating the integration and development of global biological resources, science and technology, industry, capital”, the summit calls on experts, scholars and entrepreneurs at home and abroad to discuss new models, explore new directions and build a new environment around issues, technology trends, industry information and policy in the development of biology and life science technology and industry.

Previous summits

2017

The Summit was held 21–23 September 2017. Its theme was to develop wisdom and great health, build the new engine of industry. It was supported by the Ministry of science and technology, China Biotechnology Development Center, China Medicinal Biotechnology Association and the China Quality Association for Pharmaceuticals. The sponsors were Shenzhen Development and Reform Commission and Shenzhen Science and Technology Innovation Committee.

Keynote speakers

Barry Marshall, Nobel prize in Physiology or Medicine in 2005, foreign academicians of Chinese Academy of Engineering, Australian scientists.
Rao Yi, lifelong tenured professor of Peking University, director of the Science Department of Peking University.

Dialogues

Development trend and task of innovative drugs
Opportunity and challenge of big data development of health care

Professional fora

Transformation and application of nanobiological technology in medical field
Innovation application and development of big data development of health care
Prospect of innovation and entrepreneurship of precision medicine
Tumor molecular diagnosis and individualized treatment
New directions in investment of immunization therapy
Development of new cardiovascular and cerebrovascular diagnostic industry
Key technology forum for generic drug development frontier and consistency evaluation
Shenzhen Hong Kong health services Development Forum
Index system of regional health assessment for life economy
The Sixteenth International Conference on Bioinformatics--- Bioinformatics data mining and Application Forum faced for precision medical services
Discussion on biopharmaceutical industry based on Microbiology

2016

The theme was “developing green economy and creating a better life”.

Keynotes

New model of cross - Pacific cooperation in cancer precision medical industry
Advances in biological therapy and biotechnology drugs

Dialogue

BT innovation industry circle in the era of big health

Professional forum

Smart medicine in the era of big data
Cell therapy leads the revolution of medical technology
Drug listing permit holder system preach and bio innovation drug research and development forum
Development and future strategy of medical robot industry
The “bounce back” of xenotransplantation
Gene sequencing industry development
“Shenzhen international Bio Valley” precision medical international collaborative innovation
Health industry and scientific and technological innovation development in Shenzhen, Hong Kong

Participants

Dinshaw J. Patel, professor of MemorialSloan-Kettering Cancer Center Fellow of the National Academy of Science, Fellow of American Academy of Arts and Sciences
Hans Lehrach, Academician of Germany's Academy of Sciences
Peter. E. Lobie, PhD, Professor, National Cancer Institute, Singapore; Academician, Royal Academy of Sciences, New Zealand
Robert Desimone Member of US National Academy of Sciences, Doris and Don Berkey Professor, Dept of Brain and Cognitive Sciences, Director of McGovern Institute for Brain Research at MIT
Byoung S. Kwon, PhD, Investigator, Korea National Cancer Institute
Christopher Reinhard, Chairman, Taxus Cardium Pharmaceutical Group
Chen Yuzong, Professor of the National University of Singapore
David Baghurst, chairman of Isis innovation of science and Technology (HK) Co., Ltd
Dr. George Ye, founder, Chief Scientific Officer and President of Anogen-Yes Biotech Laboratories
Guoping Feng, Poitras Professorship of Neuroscience at the Department of Brain and Cognitive Sciences
Gerard Marriott, PhD, Professor, UC Berkeley, Department of Biophysics
Hendrik-Jan Schuurman, Consultant and Director, SchuBiomed Consultancy (Utrecht, the Netherlands)
Ivor Royston, Professor of University of California, San Diego, School of Medicine
Je Ho Lee, MD, Clinical Professor and Director, Cancer Center/Gynecology, Bundang Cha University Hospital
Low Kin Huat, Professor of Nanyang Technological University
Lung-Ji Chang, Director of immunology, Cancer Center in Florida University
Peng Bin, Director of Novartis Cancer Drug Translational Science Center, Shanghai, China
Richard Y. Zhao, PhD, Professor, Institute of Microbiology, Immunology, Human Viruses, University of Maryland
Tadashi Matsumoto, PhD, President and CEO, ReqMed
Wei-Wei Zhang, MD, PhD, Chairman, Adventin Inc.; Honorary President of US-China Entrepreneurs Association
Xurong Jiang, PhD, Chief, Quality and Technology, BioVentures, AstraZeneca
Yves Decadt, PhD, CEO BioLingus
Yifan Dai, Associate Professor, Thomas E. Starzl Transplantation Institute, University of Pittsburgh
Yiwu He, PhD, MBA Senior Vice President, Global Head of R&D, BGI
Gu Ying, Academician of the Chinese Academy of Sciences
Wei Yuquan, Vice President of Sichuan University, Academician of Chinese Academy of Sciences
Jizong Zhao, Member of Chinese Academy of Sciences, director of the Department of Neurosurgery, Tiantan hospital
Zhang Bo, Professor in Tsinghua University, Fellow of the Chinese Academy of Sciences
Gao Changqing, chief physician of General Hospital of PLA, Academician of Chinese Academy of Engineering
Lanjuan Li, Academician of Chinese Academy of Engine
Shi Xuemin, doctoral tutor, Chinese Academy of Engineering
Qimin Zhan, Member of Chinese Academy of Engineering, Professor at Peking Union Medical College Director of Peking University Health Science Center
Chen Wei, China International Economic and Exchange Center, director of the Institute of Innovation and Development
Xun Chen, Independent Director of Board and President of the Special Commission, Qihoo 360 Technology Co
Zhekuan Fu, Chairman of QF Capital
Benjamin W. Wah, American Association for the Advancement of Science (AAAS), Provost of the Chinese University of Hong Kong
Han Weidong, Director of the Laboratory of Immunology, PLA General Hospital (i.e. 301 Hospital)
Bai Lu Professor and Executive Vice Dean, School of Medicine, Tsinghua University; Research focus on neuroscience, translational research and drug discovery
Baoyan Liu, Vice president of China Academy of Chinese Medical Sciences
Hong Liu, Hong Liu, IBM General Manager of China Health and Life Sciences Industry
Liu Guoqing, the executive director of China International Capital
Liangxue Lai, Dean, College of Animal Science and Veterinary Medicine, Jilin University
Zuhong Lu, Country "Thousand Talents Program" Distinguished experts
Dinggang Li, MD, President, Beijing Daopei Hospital
Li Xiaoyu, Associate Professor Hong Kong University
Li XiaoYi, Dr. Lee's Pharmaceutical Holdings Limited chief executive and founder, vice chairman of the Hong Kong Biotechnology Association
Dr. Jian Ni, CEO, The National Engineering Research Center of Antibody Medicine (CMAB)
Nianmin Qi, Professor of School of Pharmacy in Shanghai Jiaotong University
Lingyun Sun, Vice President of Nanjing drum tower hospital affiliated to Nanjing university medical school, Supervisor of Ph.D candidates
Tian Wei, President of Beijing Ji Shui Tan Hospital
Mingyuan Wu, CEO of Zhongyuan Union cell gene engineering Corporation Limited
Wang Hongguang, Advisor, Deputy Director General, Chinese Academy of Science and Technology for Development (CASTED), Ministry of Science and Technology
Steven Wang, Managing and Founding Partner
Wang Shuxin, the chief scientist of Shandong Weigao surgical robot Co. Ltd., director of the joint research center of Tianjin University - Weigao group medical robot, Tianjin University professor
WenXiong Wang, the Chair Professor in the Life Science Division and the Director of Marine Environmental Laboratory in Shenzhen Research Institute of the HKUST
Min Xue, CEO of United Imaging
Xu Huafeng, China Health Care Association, vice chairman and secretary general
Zhengguo Yang, chairman of the board, Shanxi Aierfu ActivTissue Engineering Co., Ltd
Zhang Lianshan, deputy general manager and global vice president for research and development of Jiangsu Hengrui pharmaceutical co., Ltd
Liwei Zhang, vice president of Beijing Tian Tan Hospital, Capital Medical University
Zhang Fenglou, former Deputy Minister of Health, former chairman of the China Health Care Association
Zhang Ji, chief scientist for new drug research and development of Hopeful Ecological Company pharmaceutical, Guangdong
Yuan-Ting Zhang, fellow of International Academy for Medical and Biological Engineering
Karl Tsim, chair professor of Division of Life Science, and the Director of Center for Chinese Medicine R & D at the Hong Kong University of Science and Technology (HKUST)
Zhiming Cai, Chief Scientist of National ‘‘973’’ Key Basic Research
Cai Lintao, principal investigator and the director of Institute of Biomedicine and Biotechnology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Science
Jiankui He, chairman Of Direct Genomics Co., Ltd
Ningzheng Luo, founder and CEO of ‘Your Online Hospital’
Ye Li, director of Scientific Research and Research Center for Biomedical Information Technology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences
Li Guanglin, director of institute of advanced integration technology (SIAIT), SIAT
Chen Qiu,（Chairman of the forum, host） Director of Shenzhen People's Hospital
Xizhuo Sun, Director of Shenzhen Luohu Hospital Group
Xiangjun Zhou, Ph.D, Vice CEO of HRYZ BIOTECH Co. Ltd, chief scientist

2015

The theme was “developing green economy and creating a better life”.

Keynotes

Fight cancer: CarT therapy for cancer
Translational medicine: opportunities and challenges
Biotechnology innovation in the era of great health

Dialogues

Opportunities and challenges in the era of precision medical care
Biological medicine, medical technology and instrument supervision policy

Professional forum

The integration of global customers and industry
Brain & Future
New techniques and trends in cell therapy and The awarding ceremony of Shenzhen synthetic cell bank, Shenzhen (North Science) regional cell preparation center
New medical materials and 3D printing
Internet Finance + Medical Innovation Seminar
Synthetic biology and industrial applications
Modernization and internationalization of traditional Chinese Medicine
Explore the innovation way of Chinese pharmaceutical enterprises in new situation

2014

Keynotes

The new future of human biology and biomedical research
Intelligence development of big data and medical health industry

Professional forum

High end biomedical engineering in the information age
Chinese medicine and marine biological medicine industry development forum
Application of biotechnology in modern agricultural economy
Cell therapy and regenerative medicine
Personalized medical care in the whole genome era
Policy innovation in the field of health care

References

This article needs additional or more specific categories. Please help out by adding categories to it so that it can be listed with similar articles. (October 2023)

Category:

Intergovernmental organizations